Skip to content

Clinical trials

Carcinoma, Non-Small-Cell Lung trials in Bosnia and Herzegovina

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Country / region: Bosnia and Herzegovina Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20041
20081
20111
20131
20142
20161
20171
20182
20191
20243

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Terminated3
Active, not recruiting2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche4
Synta Pharmaceuticals Corp.2
Aileron Therapeutics, Inc.1
Boehringer Ingelheim1
Centus Biotherapeutics Limited1
Eli Lilly and Company1
Jiangsu Hansoh Pharmaceutical Co., Ltd.1
Mylan Pharmaceuticals Inc1
Samsung Bioepis Co., Ltd.1
Sandoz1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung15
Lung Neoplasms1
Neoplasms1
Small Cell Lung Carcinoma1

Trials

Showing 76 to 15 of 15. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.